During the past decade, Utah Cancer Specialists conducted 72 clinical trials. In the 10-year time frame, 72 clinical trials started and 47 clinical trials were completed, i.e. on average, 65.3% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 29 clinical trials were completed. i.e. 116% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Utah Cancer Specialists" #1 sponsor was "Novartis Pharmaceuticals" with 15 trials, followed by "Eli Lilly and Company" with 7 trials sponsored, "Pfizer" with 7 trials sponsored, "Bristol-Myers Squibb" with 5 trials sponsored and "Celgene" with 5 trials sponsored. Other sponsors include 63 different institutions and companies that sponsored additional 47 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Utah Cancer Specialists" #1 collaborator was "Merck Sharp & Dohme LLC" with 6 trials as a collaborator, "Bristol-Myers Squibb" with 3 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator and "Alliance Foundation Trials, LLC." with 1 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Utah Cancer Specialists" are "Breast Cancer" (12 trials), "Ovarian Cancer" (10 trials), "Pancreatic Cancer" (7 trials), "Melanoma" (6 trials) and "Multiple Myeloma" (5 trials). Many other conditions were trialed in "Utah Cancer Specialists" in a lesser frequency.

Most popular intervention types in "Utah Cancer Specialists" are "Drug" (102 trials), "Biological" (8 trials), "Other" (6 trials), "Combination Product" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Pembrolizumab" (10 trials), "Abemaciclib" (5 trials), "Bevacizumab" (5 trials) and "Dexamethasone" (5 trials). Other intervention names were less common.

The vast majority of trials in "Utah Cancer Specialists" are 82 trials for "All" genders, 17 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "Utah Cancer Specialists". undefined are not yet recruiting, 13 are recruiting, 25 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 47 completed trials in Utah Cancer Specialists, undefined suspended trials, and 21 terminated clinical trials to date.

Out of the total trials that were conducted in Utah Cancer Specialists, 11 "Phase 1" clinical trials were conducted, 40 "Phase 2" clinical trials and 59 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".

Utah Cancer Specialists has several departments that took part in Clinical trials: "Utah Cancer Specialists-Salt Lake City" - 130 trials, "Utah Cancer Specialists at UCS Cancer Center" - 69 trials, "Northern Utah Cancer Associates SC" - 5 trials, "Utah Cancer Specialists" - 2 trials